Name: Effect of Anti-c-fms Antibody on Osteoclast Formation and Proliferation of Osteoclast Precursor In Vitro (Video) | JoVE Journal
Uploaded: 2019-03-18T13:30:00.000+00:00
Duration: 7 min 51 s
Description: Learn to generate osteoclasts from murine bone marrow using M-CSF and RANKL or TNF-alpha. This protocol demonstrates how Anti-c-fms antibody inhibits osteoclast formation for studying inflammatory bone diseases.

ai_agent_IP

ai_agent

maintenance

instantTrialDurationMinutes

isBiopharma

enableNewMyJoveSectionDesign

educationFeatures

seoMetaApi

ai_copilot_institution_blacklist

ai_chat_institution_blacklist

freeAccessWindow

ssoRoleCapture

scheduledMaintenanceBanner

joveLabsFeatures

disable_autoplay_for_bots

extended_trial_duration

5 minutes

playerTrialDesktop

This work was supported in part by a JSPS KAKENHI grant from the Japan Society for the Promotion of Science (No. 16K11776 to H. K., No. 17K17306 to K. S., No. 16K20637 to K. K., No. 16K20636 to M. S., No. 18K09862 to I. M.).&#160;

All animal procedures and animal care were performed according to Tohoku University rules and regulations.
1. Murine Hindlimb Dissection and Handling
<ol>
	<li>Before dissection, fill a plate with approximately 50 mL of &#945;-MEM depending on the size of the container and place it on ice. This will serve as a collection container until the dissection of all bones is complete. For this and subsequent experiments, use &#945;-MEM containing 10% fetal bovine serum (FBS), 100 IU/mL penicillin G, and 100 &#956;g/mL streptomycin.</li>
	<li>Euthanize C57Bl/6J mouse by inhalation of an overdose of 5% isoflurane.</li>
	<li>Fix the mouse in a supine position using pins pierced through the palms and feet and spray thoroughly with 70% ethanol.</li>
	<li>Make a skin incision using sterile surgical scissors and tweezers at the level of the hip and extend it down to the feet exposing the muscles.</li>
	<li>Cut the tendon attaching the quadriceps muscle and the tendon attaching the hamstring muscle to the bone. Peel away the muscles exposing both hip and knee joints. Locating these tendons will ease freeing both muscles from their attachments without leaving soft tissue tags. Do not cut into the bone.</li>
	<li>Position the scissors between the head of the femur and the joint space and cut into it freeing the femur but keeping the bone intact. This will enable detachment of the bones without the risk of exposing the bone marrow.</li>
	<li>Similarly cut away the muscles attaching to the tibia. Cut the tibia free from its attachment at the ankle joint keeping the bone intact to avoid contamination.</li>
	<li>Scrape any remaining soft tissue from the femur and tibia using the scissors blades and kimwipe and place it in a plate with &#945;-MEM placed on ice.</li>
</ol>
2. Murine Hindlimb Bone Marrow Isolation
<ol>
	<li>Fill a 30 G needle syringe with &#945;-MEM.</li>
	<li>Disconnect the tibia and femur away from the knee joint.</li>
	<li>Cut the ends of the long bone from both sides using scissors.</li>
	<li>Hold the bone from the shaft using tweezers, insert the needle into the marrow space of the bone and slowly flush the content of the marrow into a 6 cm culture dish. The bone will appear white, indicating the extraction of all bone marrow content. Repeat for all bones.</li>
	<li>Strain the bone marrow extract using a 40 &#956;m nylon cell strainer into a 50 mL conical centrifuge tube and centrifuge at 300 x g for 5 min.</li>
	<li>Discard the supernatant, wash with 5 mL of &#945;-MEM, and centrifuge at 300 x g for 5 min. Repeat wash for a total of 2 times.</li>
	<li>Resuspend the pellet in 10 mL of &#945;-MEM and perform a cell count using a hemocytometer as follows:
	<ol>
		<li>Make a 1:1 dilution of cell suspension by adding 10 &#956;L of cell suspension to 10 &#956;L of 0.4% trypan blue in a 1.5 mL tube and pipette once.</li>
		<li>Cover the hemocytometer chamber with a slide cover and transfer the dye suspension to the hemocytometer. It is important not to overfill or underfill the chamber and allow the suspension to fill the chamber by capillary action.</li>
		<li>Place the hemocytometer on a microscope stage. Using 10x objective, focus on the center square. Count all cells bound by 3 lines. To make sure that cells are not counted twice, count the upper and right corners of each square. Dead cells will appear dark blue, these are excluded from the count.</li>
	</ol>
	</li>
	<li>Depending on the downstream application, seed the cells into an appropriate culture vessel. For this particular experiment, follow section 3.</li>
</ol>
3. Generation of BMM
<ol>
	<li>Seed 1 x 107 cells/10 mL in a 10 cm culture dish and add M-CSF 100 ng/mL. The final concentration of M-CSF is 100 ng/mL of culture medium. Incubate the culture at 37 &#176;C, 5% CO2 for 3 days.</li>
	<li>After 3 days, remove the culture medium, wash the cells vigorously with 10 mL of phosphate buffered saline (PBS) twice to remove non-adherent cells, add 5 mL of room temperature 0.02% trypsin-EDTA in PBS and incubate at 37 &#176;C, 5% CO2 for 5 min.</li>
	<li>Detach the cells by thorough pipetting. Make sure that the cells have been detached by observing the culture under a microscope (the cells should appear rounded and floating in media). If the cells remain attached, repeat pipetting thoroughly to detach them. When the cells have been detached, add 5 mL of &#945;-MEM to inactivate the reaction.</li>
	<li>Collect the cells into a 50 mL conical tube and centrifuge at 300 x g for 5 min. Discard the supernatant, and wash with 5 mL of &#945;-MEM.</li>
	<li>Centrifuge at 300 x g for 5 min and resuspend the pellet in 10 mL of &#945;-MEM.</li>
	<li>Perform a cell count as previously described in step 2.7.1.</li>
	<li>Seed 1 x 106 cells/10 mL in a 10 cm culture dish and add M-CSF 100 ng/mL. The final concentration of M-CSF is 100 ng/mL of culture medium. Incubate the culture at 37 &#176;C, 5% CO2 for 3 days.</li>
</ol>
4. Generation of Osteoclasts from BMM as Osteoclast Precursors
<ol>
	<li>After 3 days, harvest the attached cells which represent BMM as osteoclast precursors, follwoing steps 3.2-3.7.</li>
	<li>Seed BMM at 5 x 104 cells/200 &#956;L of &#945;-MEM in a 96 well plate. Add RANKL for a final concentration of 50 ng/mL or TNF-&#945; for a final concentration of 100 ng/mL. Add M-CSF for a final concentration of 100 ng/mL to each well.</li>
	<li>Add anti-c-fms antibody (final concentrations of 0, 1, 10, 100, 1000 ng/mL) to each well.</li>
	<li>Incubate at 37 &#176;C, 5% CO2 for 4 days. Change media every other day for 4 days.</li>
</ol>
5. Tartrate-resistant Acid Phosphatase (TRAP) Stain
<ol>
	<li>After 4 days of incubation, gently aspirate the culture medium of each well. Wash each well once with 200 &#956;L of room temperature 1x PBS.</li>
	<li>Add 200 &#956;L of 10% formalin to each well for fixation and incubate for 1 h at room temperature. Aspirate the formalin and wash each well 3 times with deionized water.</li>
	<li>Add 200 &#956;L of 0.2% Triton X-100 in PBS to each well for permeabilization and incubate for 1 h at room temperature. Aspirate the Triton X-100 and wash each well 3 times with deionized water.</li>
	<li>Add 200 &#956;L of TRAP stain solution to each well. Visualize the stain under the microscope. It will take from 10-30 min for the stain to develop properly.</li>
	<li>Aspirate the stain and wash each well with deionized water 3 times, and air dry. Keep at room temperature to use in further observation.</li>
</ol>
6. Proliferation Assay
<ol>
	<li>Seed BMM as osteoclast precursors at 5 x 103 cells/200 &#956;L of &#945;-MEM in a 96 well plate. Add M-CSF for a final concentration of 100 ng/mL to each well.</li>
	<li>Add anti-c-fms antibody (final concentrations of 0, 1, 10, 100, 1,000 ng/mL) and incubate at 37 &#176;C, 5% CO2 for 3 days without medium change.</li>
	<li>After 3 days, wash the cells with 1x PBS. Add 100 &#956;L of &#945;-MEM to each well.</li>
	<li>Add 10 &#956;L of cell counting kit solution and incubate at 37 &#176;C, 5% CO2 for 2 h and determine the absorbance of each well at 450 nm using a microplate reader.</li>
</ol>

<ol><li>Crotti, T. N., Dharmapatni, A. A., Alias, E., Haynes, D. R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Osteoimmunology%3A+Major+and+Costimulatory+Pathway+Expression+Associated+with+Chronic+Inflammatory+Induced+Bone+Loss%5BTitle%5D)+AND+%22Journal+of+Immunology+Research%22%5BJournal%5D)">Osteoimmunology: Major and Costimulatory Pathway Expression Associated with Chronic Inflammatory Induced Bone Loss.</a> Journal of Immunology Research. 2015, 281287(2015).</li>
<li>Teitelbaum, S. L. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Bone+resorption+by+osteoclasts%5BTitle%5D)+AND+%22Science%22%5BJournal%5D)">Bone resorption by osteoclasts.</a> Science. 289 (5484), 1504-1508 (2000).</li>
<li>Azuma, Y., Kaji, K., Katogi, R., Takeshita, S., Kudo, A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Tumor+necrosis+factor-alpha+induces+differentiation+of+and+bone+resorption+by+osteoclasts%5BTitle%5D)+AND+%22Journal+of+Biological+Chemistry%22%5BJournal%5D)">Tumor necrosis factor-alpha induces differentiation of and bone resorption by osteoclasts.</a> Journal of Biological Chemistry. 275 (7), 4858-4864 (2000).</li>
<li>Kobayashi, K., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Tumor+necrosis+factor+alpha+stimulates+osteoclast+differentiation+by+a+mechanism+independent+of+the+ODF%2FRANKL-RANK+interaction%5BTitle%5D)+AND+%22Journal+of+Experimental+Medicine%22%5BJournal%5D)">Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction.</a> Journal of Experimental Medicine. 191 (2), 275-286 (2000).</li>
<li>Kim, N., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Osteoclast+differentiation+independent+of+the+TRANCE-RANK-TRAF6+axis%5BTitle%5D)+AND+%22Journal+of+Experimental+Medicine%22%5BJournal%5D)">Osteoclast differentiation independent of the TRANCE-RANK-TRAF6 axis.</a> Journal of Experimental Medicine. 202 (5), 589-595 (2005).</li>
<li>Redlich, K., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Osteoclasts+are+essential+for+TNF-alpha-mediated+joint+destruction%5BTitle%5D)+AND+%22Journal+of+Clinical+Investestigation%22%5BJournal%5D)">Osteoclasts are essential for TNF-alpha-mediated joint destruction.</a> Journal of Clinical Investestigation. 110 (10), 1419-1427 (2002).</li>
<li>Abu-Amer, Y., Ross, F. P., Edwards, J., Teitelbaum, S. L. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Lipopolysaccharide-stimulated+osteoclastogenesis+is+mediated+by+tumor+necrosis+factor+via+its+P55+receptor%5BTitle%5D)+AND+%22Journal+of+Clinical+Investestigation%22%5BJournal%5D)">Lipopolysaccharide-stimulated osteoclastogenesis is mediated by tumor necrosis factor via its P55 receptor.</a> Journal of Clinical Investestigation. 100 (6), 1557-1565 (1997).</li>
<li>Zha, L., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((TNF-alpha+contributes+to+postmenopausal+osteoporosis+by+synergistically+promoting+RANKL-induced+osteoclast+formation%5BTitle%5D)+AND+%22Biomedicine+%26+Pharmacotherapy%22%5BJournal%5D)">TNF-alpha contributes to postmenopausal osteoporosis by synergistically promoting RANKL-induced osteoclast formation.</a> Biomedicine & Pharmacotherapy. 102, 369-374 (2018).</li>
<li>Kitaura, H., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((M-CSF+mediates+TNF-induced+inflammatory+osteolysis%5BTitle%5D)+AND+%22Journal+of+Clinical+Investigation%22%5BJournal%5D)">M-CSF mediates TNF-induced inflammatory osteolysis.</a> Journal of Clinical Investigation. 115 (12), 3418-3427 (2005).</li>
<li>Kimura, K., Kitaura, H., Fujii, T., Hakami, Z. W., Takano-Yamamoto, T. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Anti-c-Fms+antibody+inhibits+lipopolysaccharide-induced+osteoclastogenesis+in+vivo%5BTitle%5D)+AND+%22FEMS+Immunology+and+Medical+Microbiology%22%5BJournal%5D)">Anti-c-Fms antibody inhibits lipopolysaccharide-induced osteoclastogenesis in vivo.</a> FEMS Immunology and Medical Microbiology. 64 (2), 219-227 (2012).</li>
<li>Kimura, K., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((An+anti-c-Fms+antibody+inhibits+osteoclastogenesis+in+a+mouse+periodontitis+model%5BTitle%5D)+AND+%22Oral+Diseases%22%5BJournal%5D)">An anti-c-Fms antibody inhibits osteoclastogenesis in a mouse periodontitis model.</a> Oral Diseases. 20 (3), 319-324 (2014).</li>
<li>Kitaura, H., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((An+M-CSF+receptor+c-Fms+antibody+inhibits+mechanical+stress-induced+root+resorption+during+orthodontic+tooth+movement+in+mice%5BTitle%5D)+AND+%22Angle+Orthodontist%22%5BJournal%5D)">An M-CSF receptor c-Fms antibody inhibits mechanical stress-induced root resorption during orthodontic tooth movement in mice.</a> Angle Orthodontist. 79 (5), 835-841 (2009).</li>
<li>Kitaura, H., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((An+anti-c-Fms+antibody+inhibits+orthodontic+tooth+movement%5BTitle%5D)+AND+%22Journal+of+Dental+Research%22%5BJournal%5D)">An anti-c-Fms antibody inhibits orthodontic tooth movement.</a> Journal of Dental Research. 87 (4), 396-400 (2008).</li>
<li>Bettina, A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((M-CSF+Mediates+Host+Defense+during+Bacterial+Pneumonia+by+Promoting+the+Survival+of+Lung+and+Liver+Mononuclear+Phagocytes%5BTitle%5D)+AND+%22Journal+of+Immunology%22%5BJournal%5D)">M-CSF Mediates Host Defense during Bacterial Pneumonia by Promoting the Survival of Lung and Liver Mononuclear Phagocytes.</a> Journal of Immunology. 196 (12), 5047-5055 (2016).</li>
<li>Dougall, W. C., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((RANK+is+essential+for+osteoclast+and+lymph+node+development%5BTitle%5D)+AND+%22Genes+%26+Develpoment%22%5BJournal%5D)">RANK is essential for osteoclast and lymph node development.</a> Genes & Develpoment. 13 (18), 2412-2424 (1999).</li>
<li>Wiktor-Jedrzejczak, W., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Total+absence+of+colony-stimulating+factor+1+in+the+macrophage-deficient+osteopetrotic+%28op%2Fop%29+mouse%5BTitle%5D)+AND+%22Proceedings+of+the+National+Academy+of+Sciences+of+the+United+States+of+America%22%5BJournal%5D)">Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse.</a> Proceedings of the National Academy of Sciences of the United States of America. 87 (12), 4828-4832 (1990).</li>
<li>Yang, P. T., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Increased+expression+of+macrophage+colony-stimulating+factor+in+ankylosing+spondylitis+and+rheumatoid+arthritis%5BTitle%5D)+AND+%22Annals+of+the+Rheumatic+Diseases%22%5BJournal%5D)">Increased expression of macrophage colony-stimulating factor in ankylosing spondylitis and rheumatoid arthritis.</a> Annals of the Rheumatic Diseases. 65 (12), 1671-1672 (2006).</li>
<li>Takei, I., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((High+macrophage-colony+stimulating+factor+levels+in+synovial+fluid+of+loose+artificial+hip+joints%5BTitle%5D)+AND+%22The+Journal+of+Rheumatology%22%5BJournal%5D)">High macrophage-colony stimulating factor levels in synovial fluid of loose artificial hip joints.</a> The Journal of Rheumatology. 27 (4), 894-899 (2000).</li>
</ol>

The authors have nothing to disclose.

In this study, we investigated the effect of anti-c-fms antibody on RANKL-induced osteoclast formation, TNF-&#945;-induced osteoclast formation and M-CSF-induced osteoclast precursor proliferation. We found that the effective amount of anti-c-fms antibody for the inhibition of osteoclastogenesis among RANKL-induced osteoclast formation, TNF-&#945; induced osteoclast formation and M-CSF-induced proliferation of osteoclast precursors is different.
RANKL mediates osteoclastogenesis in the presenc...

Osteoclasts are highly specialized cells, and they differentiate from hematopoietic stem cells through the fusion of multiple osteoclast precursors. They are essential for healthy bone remodeling and contribute to pathologic bone resorption associated with inflammatory osteolytic diseases such as rheumatoid arthritis and periodontal disease1.
Osteoclastogenesis and osteoclast function are mediated by two key factors; macrophage colony stimulating factor (M-CSF) and receptor activator of nuclear factor kappa-B ligand (RANKL). Both M-CSF and RANKL are important for osteoclast differentiation2. Another factor which has been shown to induce osteoclast formation from bone marrow macrophages in vitro is tumor necrosis factor alpha (TNF-&#945;)3,4,5. TNF-&#945; mediated osteoclast formation has been shown to be critical for osteolysis in destructive bone diseases such as rheumatoid arthritis6, periodontal disease7, and postmenopausal osteoporosis8.
C-fms is the membrane receptor of M-CSF and mediates its action. The role of c-fms is well documented in the literature as it was demonstrated that the administration of an antibody against c-fms (anti-c-fms antibody) completely arrested osteoclastogenesis in an arthritis model as well as in TNF-&#945; induced bone erosions while osteoclastogenesis distant from the inflamed joint was still robust9. Administration of anti-c-fms antibody inhibited osteoclast formation and bone resorption induced by lipopolysaccharide (LPS) in mouse calvariae10 as well as in LPS-induced&#160; periodontitis model11. Moreover, anti-c-fms antibody inhibited mechanical stress-induced root resorption during orthodontic tooth movement12, as well as orthodontic tooth movement and bone resorption associated with orthodontic tooth movement13.
M-CSF has been reported to have other functions which are essential to the host immune response. The absence of M-CSF in op/op mice with bacterial pneumonia lead to the increase of bacterial burden and bacterial dissemination to the liver with hepatic necrosis14. Therefore, M-CSF is important for immunological response in the protection from infection.
This study demonstrates the effect of anti-c-fms antibody on M-CSF and RANKL or TNF-&#945; induced osteoclast formation in vitro and M-CSF induced proliferation of osteoclast precursors. This protocol demonstrates the isolation of murine bone marrow cells from long bones, and the steps to generate bone marrow macrophages (BMM) which are regarded as osteoclast precursors and to induce the differentiation of BMM into multinuclear osteoclasts by two methods; either RANKL or TNF-&#945;. The protocol also compares the arrest of osteoclastogenesis in both methods using anti-c-fms antibody.
The process by which bone marrow is extracted and subsequently used to generate osteoclast precursors is reliable in producing large quantities of pure osteoclast cultures which can be used in multiple downstream applications such as drug testing. The use of either RANKL or TNF-&#945; to induce osteoclastogenesis in this protocol distinguishes osteoclastogenesis as a physiologic process (RANKL) from osteoclastogenesis as a pathologic process (TNF-&#945;), which in turn provides two alternative procedures to guide the decision of which one is superior in terms of the reagents to be used in downstream applications. This protocol also provides a method by which we can determine a suitable concentration of anti-c-fms antibody that can be safely used for later studies involved in bone resorption and osteolytic diseases.

<table><tbody><tr><td>Anti-c-Fms antibody</td><td></td><td></td><td>AFS98, a rat monoclonal, antimurine, c-Fms antibody (IgG2a)</td></tr><tr><td>TNF-&amp;alpha;</td><td></td><td></td><td>Recombinant murine TNF-&amp;alpha; prepared in our laboratory. TNF-&amp;alpha; cDNA fragment cloned by RT-PCR and cloned into a pGEX-6P-I (Amersham Biosciences, Piscataway, NJ) to generate a GST-fusion protein. GST-TNF-&amp;alpha; was expressed in Escherichia coli BL21 cells cells (Stratagene, La Jolla, CA). The cells were lysed under nondenaturing conditions and GST-TNF-&amp;alpha; was purified over a glutathione-Sepharose column. GST was cleaved off by PreScission Protease (Amersham Biosciences) by manufacturer&amp;rsquo;s directions and was removed by a glutathione-Sepharose column.</td></tr><tr><td>RANKL</td><td>PEPROTECH</td><td>315-11</td><td>Recombinant Murine sRANK Ligand, Source: &lt;em&gt;E. coli&lt;/em&gt;</td></tr><tr><td>M-CSF</td><td></td><td></td><td>Recombinant human M-CSF. 1/10 vol of CMG14&amp;ndash;12 cell line culture supernatant at 5x10&lt;sup&gt;6&lt;/sup&gt;&amp;nbsp;cells in a 10 cm suspension culture dish.</td></tr><tr><td>&amp;alpha;-MEM</td><td>Wako</td><td></td><td>with L-Glutamine and phenol red</td></tr><tr><td>Fetal Bovine Serum</td><td>Biowest</td><td>s1820-500</td><td>Fetal Bovine Serum French Origin</td></tr><tr><td>Culture dish</td><td>Corning</td><td></td><td>100 mm x 20 mm style dish</td></tr><tr><td>96-well plate</td><td>Thermofischer Scientific</td><td></td><td>Nun clon Delta surface</td></tr><tr><td>Cell counting kit-8</td><td>Dojindo, Kumamoto, Japan</td><td></td><td></td></tr><tr><td>Microplate reader</td><td>Sunrise REMOTE; Tekan Japan, Kawasaki, Japan</td><td></td><td></td></tr><tr><td>Cell strainer</td><td>Corning</td><td></td><td>40 &amp;mu;m Nylon</td></tr><tr><td>Centrifuge tube</td><td>Corning</td><td></td><td>50 mL CentriStar cap</td></tr><tr><td>Triton X-100</td><td>Wako</td><td></td><td>Polyoxyethylene (10) Octyphenyl ether</td></tr></tbody></table>

effect of anti-c-fms antibody on osteoclast formation and proliferation of osteoclast precursor in vitro

Effect of Anti-c-fms Antibody on Osteoclast Formation and Proliferation of Osteoclast Precursor In Vitro

Bone remodeling is a complex process and it involves periods of deposition and resorption. Bone resorption is a process by which bone is broken down by osteoclasts in response to different stimuli. Osteoclast precursors differentiate into multinuclear osteoclasts in response to macrophage colony stimulating factor (M-CSF) and receptor activator of nuclear factor Kappa-B ligand (RANKL). Under pathologic conditions, the cytokine profile is different and involves a mixture of inflammatory cytokines. Tumor necrosis factor alpha (TNF-&#945;) is one of the most important cytokines as it is found in large amounts in areas involved with inflammatory osteolysis. The purpose of this protocol is to provide a method by which murine bone marrow is isolated to generate osteoclasts through induction with M-CSF and either RANKL or TNF-&#945; which will be subsequently inhibited by increasing doses of anti-c-fms antibody, the receptor for M-CSF. This experiment highlights the therapeutic value of anti-c-fms antibody in diseases of inflammatory bone resorption.

The purpose of this protocol is to evaluate the effect of anti-c-fms antibody on osteoclast formation in the presence of RANKL or TNF-α, and to determine the effect of M-CSF on osteoclast precursors proliferation. In this protocol, we have provided a reliable process by which large quantities of pure osteoclast cultures are generated. We have also provided a way to test anti-c-fms antibody suitable concentration for inhibiting osteoclast formation under different culture conditions.
<...

This protocol includes dissection of murine long bones and bone marrow isolation, to generate bone marrow macrophages and produce osteoclasts using macrophage colony stimulating factor (M-CSF) and receptor activator of nuclear factor Kappa-B ligand (RANKL) or tumor necrosis factor alpha (TNF-&#945;) and their arrest by anti-c-fms antibody, M-CSF receptor.

Bone remodeling is a complex process and it involves periods of deposition and resorption. Bone resorption is a process by which bone is broken down by ...

effect-anti-c-fms-antibody-on-osteoclast-formation-proliferation

Research

JoVE Journal

Immunology and Infection

In this video, we demonstrate the effect of different anti-c-fms antibody concentrations on osteoclastogenesis, which is the process of osteoclast formation from osteoclast progenitors.

Effect of the Anti C-fms Antibody on Osteoclastogenesis in Mouse Bone Marrow Cells In Vitro

Differentiation of precursor cells into osteoclasts is regulated by cytokines and growth factors. Here, a novel gene transfer technique for differentiation of osteoclasts in vivo and cell culture protocols for differentiating precursor cells into osteoclasts in vitro as a method to study the effects of cytokines on osteoclastogenesis are described.

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders

Osteoclasts are the principal bone-resorbing cell in the body. An ability to isolate osteoclasts in large numbers has resulted in significant advances in the understanding of osteoclast biology. In this protocol, we describe a method for isolation, cultivating and quantifying osteoclast activity in vitro.

Osteoclast Derivation from Mouse Bone Marrow

Notch signaling is a form of cellular communication that relies upon direct contact between cells. To properly induce Notch signaling in vitro, Notch ligands must be presented to cells in an immobilized state. This protocol describes methods for in vitro stimulation of Notch signaling in mouse osteoclast precursors.

Stimulation of Notch Signaling in Mouse Osteoclast Precursors

This manuscript describes a protocol to isolate and culture osteoclasts in vitro from mouse bone marrow, and to study the role of the mammalian/mechanistic target of rapamycin complex 1 in osteoclast formation.

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation

Osteoclasts are tissue-specific macrophage polykaryons derived from the monocyte-macrophage lineage of hematopoietic stem cells. This protocol describes how to isolate bone marrow cells so that large quantities of osteoclasts are obtained while reducing the risk of accidents found in traditional methods.

Isolation, Purification, and Differentiation of Osteoclast Precursors from Rat Bone Marrow

Here, we present a simple and effective assay procedure for resorption pit assays using calcium phosphate coated cell culture plates.

A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro

Osteoclasts are key bone-resorbing cells in the body. This protocol describes a reliable method for the in vitro differentiation of osteoclasts from human peripheral blood monocytes. This method can be used as an important tool to further understand osteoclast biology in homeostasis and in diseases.

Differentiation of Functional Osteoclasts from Human Peripheral Blood CD14+ Monocytes

This article describes the procedure for the formation and visualization of a bacterial biofilm grown within an 8-well chamber...

In vitro Biofilm Formation in an 8-well Chamber Slide

The presented method offers a way to detect functional effective cardiotropic autoantibodies in the plasma of patients with dilated cardiomyopathy, irrespective of the specific antigen, by analysing the impact of isolated patient immunoglobulin on cellular shortening and intracellular calcium transients in isolated rat cardiomyocytes.

Measurement of Antibody Effects on Cellular Function of Isolated Cardiomyocytes

Learn to generate osteoclasts from murine bone marrow using M-CSF and RANKL or TNF-alpha. This protocol demonstrates how Anti-c-fms antibody inhibits osteoclast formation for studying inflammatory bone diseases.

Effect of Anti-c-fms Antibody on Osteoclast Formation and Proliferation of Osteoclast Precursor In Vitro

Explore More Videos